Company Overview
National HealthCare Corporation operates within the healthcare sector, specifically focusing on the Medical Care Facilities industry, where it provides essential services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. The company executes its strategy through two distinct segments: Inpatient and Homecare and Hospice Services, delivering a comprehensive range of patient care solutions across these specialized environments. This diversified operational model supports a substantial workforce of 15,278 employees, reflecting the labor-intensive nature of facility-based healthcare delivery and the significant scale required to maintain such a network. With a market capitalization of $2.50B and annual revenue reaching $1.52B, the company demonstrates a significant position in its sector, indicating that it commands a substantial share of the market capitalization relative to its revenue generation capabilities. These financial figures suggest that the organization has achieved a level of market penetration that allows it to operate with a robust asset base, positioning it as a major player in the provision of inpatient and home-based health services.
Financial Health
The company generated $1.52B in revenue over the trailing twelve months, resulting in $120.02M in net income and $173.27M in EBITDA, a structure that highlights a substantial operational cost base where expenses consume a significant portion of top-line growth. The resulting free cash flow of $108.38M provides the company with considerable financial flexibility to fund ongoing operations, maintain its extensive facility network, and potentially pursue strategic initiatives without immediate reliance on external capital markets. Profitability analysis reveals a gross margin of 39.3%, an operating margin of 8.6%, and a profit margin of 7.9%, indicating that while the company retains nearly 40% of revenue after cost of goods sold, subsequent operational expenses and overhead significantly impact the final bottom line. Liquidity and leverage metrics show that cash reserves of $255.80M far exceed total debt obligations of $87.07M, while a debt-to-equity ratio of 8.10 suggests a highly leveraged capital structure despite the strong cash position, which implies reliance on debt financing to support its asset-heavy business model. Short-term liquidity is supported by a current ratio of 1.82, indicating that the company holds sufficient current assets to cover its current liabilities with a comfortable margin of safety. Return metrics further illustrate management effectiveness, with a return on equity of 11.9% and a return on assets of 5.3%, showing that while the company generates decent returns for shareholders, the high leverage and asset intensity result in a lower return on the total asset base.
Valuation Assessment
Valuation metrics indicate that the stock trades at a P/E ratio of 20.99 on a trailing twelve-month basis, while the forward P/E ratio stands at 374.49, a disparity that implies the market expects earnings to increase significantly in the future or that current earnings do not fully reflect upcoming operational realities. The price-to-book ratio of 2.34 suggests that the market values the company at more than double its book value, indicating a premium assigned to its intangible assets, brand, and future growth prospects within the healthcare sector. Alternative valuation measures such as the price-to-sales ratio of 1.65 and an EV/EBITDA of 13.50 provide context for the stock's pricing relative to its revenue generation and earnings power, suggesting the company is valued at a premium compared to many traditional utility or stable healthcare peers. Price action over the last year has seen the stock fluctuate between a 52-week high of $174.54 and a 52-week low of $89.14, illustrating a wide trading range that reflects varying investor sentiment regarding the company's earnings trajectory and sector dynamics. The beta value of 0.59 indicates that the stock exhibits lower volatility relative to the broader market, moving less dramatically than the general market index and offering a potentially more stable investment profile for risk-averse portfolios seeking exposure to the healthcare industry.
Growth & Income
Growth dynamics are characterized by a revenue growth rate of 4.6% year-over-year alongside an earnings growth rate of 306.3% year-over-year, a divergence that implies earnings are expanding at a pace far exceeding revenue, likely due to significant one-time gains, cost efficiencies, or non-recurring adjustments impacting the bottom line. As a dividend payer, the company offers a dividend yield of 1.6% with a payout ratio of 33.0%, a level that is generally considered sustainable given the high earnings growth and the ability to retain a large portion of profits for reinvestment. The combination of a modest revenue expansion and explosive earnings growth creates a unique profile where income generation is accelerating rapidly, potentially driven by segment-specific performance or financial engineering rather than pure top-line volume increases. Overall, the company presents a mixed growth and income profile where high dividend yield and massive earnings growth coexist with steady but moderate revenue growth, offering a distinct set of characteristics for investors analyzing the intersection of income stability and capital appreciation potential.